| [1] |
ACOG. Committee Opinion No.797. Prevention of group B streptococcal early-onset disease in newborns [J]. Obstet Gynecol, 2020, 135(2): e51-e72.
|
| [2] |
Fan SR, Tasneem U, Liu XP, et al. Prevention of Perinatal Group B Streptococcus Infections [J]. Materal-fetal Med, 2020, 2(1): 1-10.
|
| [3] |
Creti R, Imperi M, Berardi A, et al. Neonatal group B streptococcus infections: prevention strategies, clinical and microbiologic characteristics in 7 years of surveillance [J]. Pediatr Infect Dis J, 2017, 36(3): 256-262.
|
| [4] |
Puopolo KM, Lynfifield R, Cummings JJ. Management of infants at risk for group B streptococcal disease [J]. Pediatrics, 2019, 144(2): 1-19.
|
| [5] |
Russell NJ, Seale AC, O′Sullivan C, et al. Risk of early-onset neonatal group B streptococcus disease with maternal colonization worldwide: systematic review and meta-analyses [J]. Clin Infect Dis, 2017, 65(suppl_2): S152-S159.
|
| [6] |
Bianchi-Jassir F, Seale AC, Kohli-Lynch M, et al. Preterm birth associated with group B streptococcus maternal colonization worldwide: systematic review and meta-analyses [J]. Clin Infect Dis, 2017, 65(suppl_2): S133-S142.
|
| [7] |
Seale AC, Bianchi-Jassir F, Russell NJ, et al. Estimates of the burden of group B streptococcal disease worldwide for pregnant women, stillbirths, and children [J]. Clin Infect Dis, 2017, 65(suppl_2): S200-S219.
|
| [8] |
Nadeau Hugh CG, Edwards RK. Infections in Pregnant Women Who Are Allergic to Penicillin [J]. Clin Obstet Gynecol, 2019, 62(4): 771-780.
|
| [9] |
ACOG. Prevention of group B streptococcus early-onset disease in newborns: ACOG committee opinion, number 782 [J]．Obstet Gynecol, 2019，134(1): e19-e40.
|
| [10] |
Verani JR, McGee L, Schrag SJ. Division of Bacterial Diseases, national Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC). Prevention of perinatal group B streptococcal disease-revised guidelines from CDC，2010 [J]. MMWR Recomm Rep, 2010, 59(RR-10): 1-36.
|
| [11] |
Darlow BA, Voss L, Lennon DR, et al. Early-onset neonatal group B streptococcus sepsis following national risk-based prevention guidelines [J]. Aust N Z J Obstet Gynaecol, 2016, 56(1): 69-74.
|
| [12] |
Madrid L, Seale AC, Kohli-Lynch M, et al. Infant GBS disease investigator group infant group B streptococcal disease incidence and serotypes worldwide: systematic review and meta-analyses [J]. Clin Infect Dis, 2017, 65(suppl_2): S160-S172.
|
| [13] |
Nanduri SA, Petit S, Smelser C, et al. Epidemiology of invasive early onset and late-onset group B streptococcal disease in the United States，2006 to 2015: multistate laboratory and population-based surveillance [J]. JAMA Pediatr, 2019, 173(3): 224-233.
|
| [14] |
Seedat F, Geppert J, Stinton C, et al. Universal antenatal screening for group B streptococcus may cause more harm than good [J]. BMJ, 2019, 364: 1-22.
|
| [15] |
Ying Q, Wang S, Lou X, et al. Burden and risk factors of invasive group B Streptococcus disease among neonates in a Chinese maternity hospital [J]. BMC Infect Dis, 2019, 19(1): 1-7.
|
| [16] |
Huang J, Lin XZ, Zhu Y, et al. Epidemiology of group B streptococcal infection in pregnant women and diseased infants in mainland China [J]. Pediatr Neonatol, 2019, 60(5): 487-495.
|
| [17] |
Nakwa FL, Lala SG, Madhi SA, et al. Neurodevelopmental Impairment at 1 Year of Age in Infants With Previous Invasive Group B Streptococcal Sepsis and Meningitis [J]. Pediatr Infect Dis J, 2020，39(9): 794-798
|
| [18] |
Yahya FB, Hathcock MA. A Retrospective Review of Neonatal Sepsis among GBS-Colonized Women Undergoing Planned Cesarean Section after Labor Onset or Rupture of Membranes [J]. Infect Dis Obstet Gynecol, 2020，2020: 1-9.
|
| [19] |
Zhu Y, Wu JY, Zheng XY, et al. Identification of group B streptococcus serotypes and genotypes in late pregnant women and neonates that are associated with neonatal early-onset infection in a South China Population [J]. Front Pediatr, 2020，8: 1-7.
|
| [20] |
Ding YJ, Wang YJ, Hsia YF, et al. Systematic review and meta-analyses of incidence for group B streptococcus disease in infants and antimicrobial resistance, China [J]. Emerg Infect Dis，2020，26(11): 2651-2659.
|
| [21] |
Stapleton RD, Kahn JM, Evans LE, et al. Risk factors for group Bstreptococcal genitourinary tract colonization in pregnant women [J]. Obstet Gynecol, 2005, 106(6): 1246-1252.
|
| [22] |
Stein RA. Group B streptococci in pregnancy: new perspectives for old challenges [J]. Int J Clin Pract, 2019, 73(5): 1-2.
|
| [23] |
Chen Z, Wen G, Cao X, et al. Group B streptococcus colonisation and associated risk factors among pregnant women: a hospital based study and implications for primary care [J]. Int J Clin Pract, 2018, 73(5): 1-7.
|
| [24] |
Rick AM, Aguilar A, Cortes R, et al. Group B streptococci colonization in pregnant Guatemalan women: prevalence, risk factors, and vaginal microbiome [J]. Open Forum Infect Dis, 2017, 4(1): ofx020.
|
| [25] |
Venkatesh KK, Vladutiu CJ, Strauss RA, et al. Association Between Maternal Obesity and Group B Streptococcus Colonization in a National U．S. Cohort[J]. J Womens Health (Larchmt), 2020，29(12): 1507-1512.
|
| [26] |
Dai W, Zhang Y, Xu Y, et al. The effect of group B streptococcus on maternal and infants′ prognosis in Guizhou, China[J]. Biosci Rep, 2019, 39(12): 1-6.
|
| [27] |
Wang X, Ma LK, Song YN, et al. Rapid Group B streptococcus screening methods in late pregnancy and the maternal-neonatal outcomes [J]. Natl Med J China, 2016, 96(15): 1188-1191.
|
| [28] |
Virranniemi M, Raudaskoski T, Haapsamo M, et al. The effect of screening-to-labor interval on the sensitivity of late-pregnancy culture in the prediction of group B streptococcus colonization at labor: a prospective multicenter cohort study [J]. Acta Obstet Gynecol Scand, 2019, 98(4): 494-499.
|
| [29] |
Williams M, Zantow E, Turrentine M. Cost Effectiveness of Latest Recommendations for Group B Streptococci Screening in the United States [J]. Obstet. Gynecol, 2020, 135(4): 789-798.
|
| [30] |
ACOG. Prevention of group B streptococcal early-onset disease in newborns: ACOG committee Opinion Summary, Number 797 [J]. Obstet Gynecol, 2020, 135(2): 489-492.
|
| [31] |
Li QY, Wang DY, Li HT, et al. Screening-based and Risk-based Strategy for the Prevention of Early-onset Group B Streptococcus/Non-group B Streptococcus Sepsis in the Neonate: A Systematic Review and Meta-analysis [J]. Pediatr Infect Dis, 2020, 39(8): 740-748.
|
| [32] |
刘平，樊尚荣．美国妇产科医师学会．"新生儿早发型B族链球菌感染预防指南"解读[J/CD]．中华产科急救电子杂志，2019, 8(4): 229-234.
|
| [33] |
杜爱能，樊尚荣．阴道B族链球菌定植产时抗生素预防的效果[J]．实用妇科内分泌电子杂志，2019, 6(22): 46-48.
|
| [34] |
Allen VM, Yudin MH. Executive and Council of The Society of Obstetricians and Gynaecologists of Canada. No.276-management of group B Streptococcus bacteriuria in pregnancy [J]. J Obstet Gynaecol Can, 2018, 40(2): e181-e186.
|
| [35] |
Di Renzo GC, Melin P, Berardi A，et al. Intrapartum GBS screening and antibiotic prophylaxis：a European consensus conference [J]. J Matern Fetal Neonatal Med, 2015, 28(7): 766-782.
|
| [36] |
Hughes RG, Brocklehurst P, Steer PJ, et al. On behalf of the Royal College of Obstetricians and Gynaecologists. Prevention of early-onset neonatal group B streptococcal disease [J]. J Obetet Gynaecol Can, 2018, 40(8): e665-e674.
|
| [37] |
Bienenfeld S, Rodriguez-Riesco LG, Heyborne KD. Avoiding inadequate intrapartum antibiotic prophylaxis for group B streptococcus [J]. Obstet Gynecol, 2016, 128 (3): 598-603.
|
| [38] |
Shane AL, Sánchez PJ, Stoll BJ. Neonatal sepsis [J]. Lancet, 2017, 390(10104): 1770-1780.
|
| [39] |
Kuzniewicz MW, Mukhopadhyay S, Li S, et al. Time to Positivity of Neonatal Blood Cultures for Early-onset Sepsis [J]. Pediatr Infect Dis J, 2020, 39(7): 634-640.
|
| [40] |
O′Sullivan CP, Lamagni T, Patel D, et al. Group B streptococcal disease in UK and Irish infants younger than 90 days，2014-15: a prospective surveillance study [J]. Lancet Infect Dis, 2019, 19(1): 83-90.
|
| [41] |
Turrentine M. Prevention of early-onset group B streptococcal disease: a pinch of probability is worth a pound of perhaps [J]. BJOG, 2019, 126(4): 513.
|
| [42] |
Gopal Rao G, Townsend J, Stevenson D, et al. Early-onset group Streptococcus infection subsequent to cessation of screening-based intrapartum prophylaxis: findings of an observational study in West London, UK [J]. BMJ Open, 2017, 7(11): 1-6.
|
| [43] |
Hasperhoven GF, Al-Nasiry S, Bekker V, et al. Universal screening versus risk-based protocols for antibiotic prophylaxis during childbirth to prevent early-onset group B streptococcal disease: a systematic review and meta-analysis [J]. BJOG, 2020, 127(6): 680-691.
|
| [44] |
Nogacka A, Salazar N, Suárez M, et al. Impact of intrapartum antimicrobial prophylaxis upon the intestinal microbiota and the prevalence of antibiotic resistance genes in vaginally delivered full term neonates [J]. Microbiome, 2017, 5(1): 93.
|
| [45] |
Abu-Raya B, Maertens K, Edwards KM, et al. Global Perspectives on Immunization During Pregnancy and Priorities for Future Research and Development: An International Consensus Statement [J]. Front Immunol，2020, 11: 1-24.
|